-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
5 Cheapest Health Care Stocks You Should Think About
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
Tricida, Inc. (NASDAQ:TCDA)
- The company's stock dropped around 98% over the past six months. The company's stock has a 52-week low of $0.13 .
- RSI Value: 28.21
- TCDA Price Action: Shares of Tricida fell 9.1% to settle at $0.1681 on Thursday and added 1.7% in today's pre-market trading.
Baxter International Inc. (NYSE:BAX)
- Wells Fargo maintained Baxter Intl with an Equal-Weight and lowered the price target from $57 to $52. The company's stock has a 52-week low of $44.47.
- RSI Value: 29.64
- BAX Price Action: Shares of Baxter International fell 0.8% to close at $45.09 on Thursday and lost 9.7% in today's pre-market trading.
Vera Therapeutics, Inc. (NASDAQ:VERA)
- Vera Therapeutics announced topline results of the Phase 2b ORIGIN clinical trial of atacicept for the treatment of IgA nephropathy. The company's stock has a 52-week low of $5.20.
- RSI Value: 20.51
- VERA Price Action: Shares of Vera Therapeutics rose 1.9% to close at $6.02 on Thursday and lost 0.8% in today's pre-market trading.
Third Harmonic Bio, Inc. (NASDAQ:THRD)
- Morgan Stanley, last month, downgraded Third Harmonic Bio from Overweight to Equal-Weight and lowered the price target from $34 to $5. The company's 52-week low is $3.89.
- RSI Value: 24.97
- THRD Price Action: Shares of Third Harmonic Bio gained 3.5% to close at $4.49 on Thursday and added 1.6% in after-hours trading.
Cutera, Inc. (NASDAQ:CUTR)
- Maxim Group maintained Cutera with a Buy and lowered the price target from $80 to $55. The company has a 52-week low of $26.51.
- RSI Value: 20.03
- CUTR Price Action: Shares of Cutera rose 3.8% to close at $28.84 on Thursday and added 2.6% in pre-market trading.
Read More: Fear & Greed Index Moves To 'Greed' Zone Following Inflation Report
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
医疗保健领域超卖次数最多的股票为买入被低估的公司提供了机会。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.
RSI是一种动量指标,它比较了股票在价格上涨的日子里的强度与价格下跌时的强度。与股票的价格走势相比,它可以让交易者更好地了解股票在短期内的表现。当 RSI 低于 30 时,资产通常被视为超卖。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是该行业主要超卖参与者的最新名单,RSI接近或低于30。
Tricida, Inc. (NASDAQ:TCDA)
Tricida, Inc. (纳斯达克股票代码:TCDA)
- The company's stock dropped around 98% over the past six months. The company's stock has a 52-week low of $0.13 .
- RSI Value: 28.21
- TCDA Price Action: Shares of Tricida fell 9.1% to settle at $0.1681 on Thursday and added 1.7% in today's pre-market trading.
- 该公司的股票在过去六个月中下跌了约98%。该公司的股票有 52 周低点 0.13 美元 。
- RSI 值: 28.21
- TCDA 价格走势: 周四,Tricida的股价下跌9.1%,收于0.1681美元,并在今天的盘前交易中上涨了1.7%。
Baxter International Inc. (NYSE:BAX)
巴克斯特国际公司 (纽约证券交易所代码:BAX)
- Wells Fargo maintained Baxter Intl with an Equal-Weight and lowered the price target from $57 to $52. The company's stock has a 52-week low of $44.47.
- RSI Value: 29.64
- BAX Price Action: Shares of Baxter International fell 0.8% to close at $45.09 on Thursday and lost 9.7% in today's pre-market trading.
- 富国银行维持了巴克斯特国际的同等权重,并将目标价从57美元下调至52美元。该公司的 股票创下 52 周低点 的 44.47 美元。
- RSI 值: 29.64
- BAX 价格走势: 周四,百特国际股价下跌0.8%,收于45.09美元,在今天的盘前交易中下跌9.7%。
Vera Therapeutics, Inc. (NASDAQ:VERA)
Vera Therapeutics公司 (纳斯达克股票代码:VERA)
- Vera Therapeutics announced topline results of the Phase 2b ORIGIN clinical trial of atacicept for the treatment of IgA nephropathy. The company's stock has a 52-week low of $5.20.
- RSI Value: 20.51
- VERA Price Action: Shares of Vera Therapeutics rose 1.9% to close at $6.02 on Thursday and lost 0.8% in today's pre-market trading.
- Vera Therapeutics公布了阿塔西普治疗IgA肾病的2b ORIGIN期临床试验的主要结果。该公司的股票有52周的股票 低点为5.20美元。
- RSI 值: 20.51
- VERA 价格走势: 周四,Vera Therapeutics的股价上涨了1.9%,收于6.02美元,在今天的盘前交易中下跌了0.8%。
Third Harmonic Bio, Inc. (NASDAQ:THRD)
第三谐波生物有限公司 (纳斯达克股票代码:THRD)
- Morgan Stanley, last month, downgraded Third Harmonic Bio from Overweight to Equal-Weight and lowered the price target from $34 to $5. The company's 52-week low is $3.89.
- RSI Value: 24.97
- THRD Price Action: Shares of Third Harmonic Bio gained 3.5% to close at $4.49 on Thursday and added 1.6% in after-hours trading.
- 摩根士丹利上个月下调了第三谐波生物的评级 从超重到等重 并将目标价格从34美元下调至5美元。该公司的52周低点为3.89美元。
- RSI 值: 24.97
- THRD 价格走势: 周四,Third Harmonic Bio的股价上涨了3.5%,收于4.49美元,盘后交易中上涨了1.6%。
Cutera, Inc. (NASDAQ:CUTR)
Cutera, Inc. (纳斯达克股票代码:CUTR)
- Maxim Group maintained Cutera with a Buy and lowered the price target from $80 to $55. The company has a 52-week low of $26.51.
- RSI Value: 20.03
- CUTR Price Action: Shares of Cutera rose 3.8% to close at $28.84 on Thursday and added 2.6% in pre-market trading.
- Maxim集团维持了Cutera的买入,并将目标价从80美元下调至55美元。该公司 创下 52 周低点 26.51 美元。
- RSI 值: 20.03
- CUTR 价格走势: 周四,Cutera的股价上涨了3.8%,收于28.84美元,盘前交易中上涨了2.6%。
Read More: Fear & Greed Index Moves To 'Greed' Zone Following Inflation Report
阅读更多: 通货膨胀报告发布后,恐惧与贪婪指数移至 “贪婪” 区域
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧